News
Summary report of the SF e-meeting, 22 September, 2010
This document is the summary report of the Stakeholder Forum e-meeting, 22 September, 2010. It presents key discussion and actions points decided at this meeting.
Summary report of the SF e-meeting, 2 March, 2011
This document is the summary report of the Stakeholder Forum e-meeting, 2 March, 2011. It presents key discussion and actions points decided at this meeting.
Summary report of the SF e-meeting, 24 November, 2010
This document is the summary report of the Stakeholder Forum e-meeting, 24 November, 2010. It presents key discussion and actions points decided at this
Summary report of the SF e-meeting, 3 May, 2011
This document is the summary report of the Stakeholder Forum e-meeting, 3 May, 2011. It presents key discussion and actions points decided at this meeting.
Summary report of the SF e-meeting, 3 May, 2012
This document is the summary report of the Stakeholder Forum e-meting, 3 May, 2012. It presents key discussion and actions points decided at this meeting.
Summary report of the SF e-meeting, 8 June, 2011
This document is the summary report of the Stakeholder Forum e-meeting, 8 June 2011. It presents key discussion and actions points decided at this meeting.
List of commentators for the WP5 JA1 Pilot Pazopanib Report
The list with commentators provides the contact information of all the organisations that properly submitted contributions. The list with commentators provides the contact
List of comments for the WP5 JA1 Pilot Pazopanib Report
The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their
WP5 JA1 Pilot Pazopanib Report+Appendix
The final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines. The joint assessment
